Department of Gynecology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
J Obstet Gynaecol Res. 2024 Aug;50(8):1420-1424. doi: 10.1111/jog.16000. Epub 2024 Jun 16.
Endometriosis, affecting 6%-10% of women of reproductive age, can lead to severe symptoms such as chronic pelvic pain and infertility. Among its rarer manifestations is abdominal wall endometriosis (AWE), which has been increasingly reported following cesarean deliveries. This case discusses a 39-year-old woman who presented with a 13-year history of cyclical pain at her cesarean section scar, exacerbated over the last year by the development of a painful abdominal mass. Medical evaluations indicated endometriosis at the scar, with further investigations including ultrasound and magnetic resonance imaging showing involvement of the rectus abdominis muscle. Elevated tumor markers HE4 and CA-125, along with a biopsy, confirmed adenocarcinoma. The patient underwent extensive surgical treatment, including the resection of the mass, hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy. Pathology confirmed moderately differentiated infiltrative adenocarcinoma originating from endometriosis. Despite the absence of postoperative chemotherapy, the patient showed no recurrence, emphasizing the effectiveness of comprehensive surgical management. This case highlights the critical importance of recognizing the potential for malignant transformation in AWE, particularly following cesarean deliveries, and underscores the necessity for vigilant monitoring and personalized treatment strategies. The management of AWE, especially when malignant transformation is suspected, necessitates a multidisciplinary approach similar to that used in ovarian cancer, focusing on rigorous surgical intervention and the potential for adjuvant therapies.
子宫内膜异位症影响着 6%-10%的育龄期女性,可导致严重症状,如慢性盆腔痛和不孕。其罕见表现之一是腹壁子宫内膜异位症(AWE),这种病症在剖宫产术后越来越多地被报道。本病例讨论了一位 39 岁女性,她因剖宫产瘢痕处周期性疼痛就诊,病史已有 13 年,近 1 年疼痛加剧,并出现了腹部肿块。医学评估提示瘢痕处存在子宫内膜异位症,进一步的超声和磁共振成像检查显示腹直肌受累。升高的肿瘤标志物 HE4 和 CA-125,以及活检,均证实为腺癌。患者接受了广泛的手术治疗,包括肿块切除、子宫切除术、双侧输卵管卵巢切除术和淋巴结切除术。病理学证实起源于子宫内膜异位症的中度分化浸润性腺癌。尽管术后未接受化疗,但患者无复发,这强调了全面手术管理的有效性。本病例强调了认识 AWE 潜在恶性转化的重要性,尤其是在剖宫产术后,需要警惕监测和个体化治疗策略。AWE 的管理,特别是怀疑恶性转化时,需要类似卵巢癌的多学科方法,重点是严格的手术干预和辅助治疗的可能性。